Capmont sells ITM stake as Telix agrees US$ 1.65 billion acquisition
Bitget2026/09/24 13:22- Capmont sold its minority stake in portfolio company ITM Isotope Technologies Munich as part of ITM’s merger with Telix Pharmaceuticals.
- Telix to acquire 100% of ITM for USD 1.65 billion upfront on a cash- and debt-free basis.
- Deal includes up to USD 700 million in milestone payments tied to regulatory and sales targets for ITM-11.
- ITM shareholders expected to hold about 23.7% of Telix upon completion.
- Closing targeted by the end of Telix’s FY2026, subject to shareholder vote, regulatory clearances, other customary conditions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The US Dollar Index fell below the 101 mark, down 0.13% intraday.
Report: US-Iran conflict disrupts OPEC+ production increase schedule, capacity review postponed to mid-November
According to media reports, the capacity review work by OPEC+ has been delayed. Originally scheduled to be completed by the end of September 2026, it has now been postponed to mid-November. This theoretically still allows OPEC+ to discuss the related results at the plenary meeting in late November. The independent capacity assessment results will directly affect the production caps approved for each member country, and some member countries have already shown significant disagreements regarding quotas, putting pressure on the alliance’s stability.
71% of UK finance leaders expect tokenization to reshape financial services: Lloyds
Crypto prices
More
